Wednesday, February 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Baird Analyst Maintains Neutral Rating on MasTec with Raised Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
FLO stock news
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Andrew Wittmann, an analyst at Baird, has decided to maintain a Neutral rating on MasTec (NYSE: MTZ) while raising the price target to $89, up from $70. This adjustment is a reflection of Wittmann’s assessment of the company’s potential performance. Wittmann, a respected Wall Street Analyst focusing on the Services sector, closely follows MasTec and other related stocks. For further insights into Baird’s research coverage and analyst insights, please visit their official website.

[bs_slider_forecast ticker=”MTZ”]

MasTec, Inc. (MTZ) Stock Surges 12.44% on March 4, 2024: Potential for Growth and Success in the Market

On March 4, 2024, MasTec, Inc. (MTZ) showed impressive stock performance, with the price of its shares increasing by $9.39 since the market last closed. This represents a significant 12.44% rise in value, with the stock closing at $84.85. Additionally, in pre-market trading, MTZ saw a further increase of $0.15 in its stock price. MTZ is currently trading in the middle of its 52-week range and is above its 200-day simple moving average. This indicates that the stock has been performing steadily and is showing positive momentum in its price movement. The increase in MTZ’s stock price can be attributed to various factors, such as positive earnings reports, strong financial performance, or favorable market conditions. Overall, MTZ’s stock performance on March 4, 2024, demonstrates its potential for growth and success in the market. Investors may consider adding MTZ to their portfolio for potential long-term gains.

MasTec, Inc. Reports Mixed Financial Results for 2023, Investors Await Future Performance

On March 4, 2024, MasTec, Inc. (MTZ) saw mixed performances in its stock as the company reported its financial results for the past year and the fourth quarter. MasTec reported total revenue of $11.99 billion for the past year, representing a 22.68% increase compared to the previous year. The total revenue remained flat at $3.28 billion for the fourth quarter. MasTec reported a net loss of $49.95 million for the past year, a significant decrease of 249.75% compared to the previous year. The net income for the fourth quarter was $753.00 thousand, a decrease of 94.73% compared to the previous quarter. Earnings per share (EPS) for MasTec were also impacted, with a reported EPS of -$0.64 for the past year, a decrease of 254.97% compared to the previous year. The EPS for the fourth quarter remained flat at $0.01. Investors and analysts will be closely monitoring MasTec’s future financial performance to see if the company can improve its profitability and EPS in the coming quarters.

Tags: MTZ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Analyst Reiterates Buy Rating on Life Time Group Holdings with Revised Price Target

MO stock news

Financial Analyst Reaffirms Positive Outlook on Metropolitan Bank Holding with Revised Price Target

CTVA stock news

Entegris Provides Earnings Guidance for Q1 FY 2024

Recommended

CleanSpark Stock

CleanSpark Navigates Record Profits and Regulatory Challenges

6 months ago
European Lithium Stock

Setback for European Lithium as Austrian Court Orders Fresh Environmental Review

2 months ago
Celularity Stock

Celularity Shares Extend Losses Despite Financial Restructuring

4 months ago
Juniper Networks Stock

Juniper Networks Integration Marks New Era for HPE

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

National Healthcare’s Financial Report: A Crucial Test Approaches

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

Trending

NexPoint Residential Stock
Dividends

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

by Felix Baarz
February 4, 2026
0

Investors in NexPoint Residential Trust will receive a comprehensive update on the company's performance when it releases...

PC Connection Stock

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

February 4, 2026
Fossil Stock

Fossil Group Stock Surges Past Key Technical Threshold

February 4, 2026
NextGen Healthcare Stock

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

February 4, 2026
Arcus Biosciences Stock

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results
  • PC Connection Set to Report Full-Year and Fourth Quarter Earnings
  • Fossil Group Stock Surges Past Key Technical Threshold

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com